Bio-Rad Laboratories | BIO - Des Atouts





Des Atouts Changement Date
Abbott USD 110.43B 23.72B 2026-03
Agilent USD 13.97B 902M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Bio Techne USD 2.59B 36.12M 2026-06
Bio-Rad Laboratories USD 10.25B 462M 2026-06
Bruker USD 6.05B 77.8M 2026-06
Charles River Laboratories USD 7.53B 198.16M 2026-06
Danaher USD 92.37B 8.82B 2026-06
General Electric Aerospace USD 127.67B 773M 2026-06
Illumina USD 6.65B 91M 2026-06
IQVIA Holdings USD 29.88B 206M 2026-06
Laboratory Of America USD 18.53B 554.8M 2026-06
Merck USD 129.8B 1.12B 2026-06
Mettler Toledo International USD 3.67B 2.03M 2026-06
Myriad Genetics USD 638.9M 34.8M 2026-06
OraSure Technologies USD 360.55M 18.62M 2026-06
Pacific Biosciences Of California USD 751.85M 30.51M 2026-06
Quest Diagnostics USD 16.94B 266M 2026-06
Repligen USD 2.95B 19.41M 2026-06
Revvity USD 12.05B 49.24M 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06
Siemens EUR 167.54B 428M 2026-06
Standard Biotools USD 639.11M 71.36M 2026-03
Thermo Fisher Scientific USD 113.17B 107M 2026-06
Tosoh JPY 1.47T 59.99B 2026-06
Waters USD 24.75B 220M 2026-06